Selected article for: "acute hypoxemic respiratory failure and admission icu"

Author: Mellado-Artigas, Ricard; Ferreyro, Bruno L.; Angriman, Federico; Hernández-Sanz, María; Arruti, Egoitz; Torres, Antoni; Villar, Jesús; Brochard, Laurent; Ferrando, Carlos
Title: High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure
  • Cord-id: seuhmwjj
  • Document date: 2021_2_11
  • ID: seuhmwjj
    Snippet: PURPOSE: Whether the use of high-flow nasal oxygen in adult patients with COVID-19 associated acute respiratory failure improves clinically relevant outcomes remains unclear. We thus sought to assess the effect of high-flow nasal oxygen on ventilator-free days, compared to early initiation of invasive mechanical ventilation, on adult patients with COVID-19. METHODS: We conducted a multicentre cohort study using a prospectively collected database of patients with COVID-19 associated acute respira
    Document: PURPOSE: Whether the use of high-flow nasal oxygen in adult patients with COVID-19 associated acute respiratory failure improves clinically relevant outcomes remains unclear. We thus sought to assess the effect of high-flow nasal oxygen on ventilator-free days, compared to early initiation of invasive mechanical ventilation, on adult patients with COVID-19. METHODS: We conducted a multicentre cohort study using a prospectively collected database of patients with COVID-19 associated acute respiratory failure admitted to 36 Spanish and Andorran intensive care units (ICUs). Main exposure was the use of high-flow nasal oxygen (conservative group), while early invasive mechanical ventilation (within the first day of ICU admission; early intubation group) served as the comparator. The primary outcome was ventilator-free days at 28 days. ICU length of stay and all-cause in-hospital mortality served as secondary outcomes. We used propensity score matching to adjust for measured confounding. RESULTS: Out of 468 eligible patients, a total of 122 matched patients were included in the present analysis (61 for each group). When compared to early intubation, the use of high-flow nasal oxygen was associated with an increase in ventilator-free days (mean difference: 8.0 days; 95% confidence interval (CI): 4.4 to 11.7 days) and a reduction in ICU length of stay (mean difference: − 8.2 days; 95% CI − 12.7 to − 3.6 days). No difference was observed in all-cause in-hospital mortality between groups (odds ratio: 0.64; 95% CI: 0.25 to 1.64). CONCLUSIONS: The use of high-flow nasal oxygen upon ICU admission in adult patients with COVID-19 related acute hypoxemic respiratory failure may lead to an increase in ventilator-free days and a reduction in ICU length of stay, when compared to early initiation of invasive mechanical ventilation. Future studies should confirm our findings.

    Search related documents:
    Co phrase search for related documents
    • active cancer and acute respiratory failure: 1, 2, 3, 4, 5
    • active cancer and additional file: 1, 2, 3, 4, 5
    • active cancer and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • active cancer and logistic regression model: 1, 2, 3, 4
    • active cancer and lymphocyte count: 1, 2, 3
    • acute hypoxemic respiratory failure and additional file: 1, 2
    • acute hypoxemic respiratory failure and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
    • acute hypoxemic respiratory failure and logistic regression model: 1, 2
    • acute respiratory failure and additional file: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory failure and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory failure and logistic regression model: 1, 2, 3, 4, 5, 6
    • acute respiratory failure and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acyclic graph and logistic regression: 1, 2, 3
    • acyclic graph and logistic regression model: 1
    • additional evidence and logistic regression: 1, 2, 3, 4, 5, 6, 7
    • additional evidence and lymphocyte count: 1
    • additional file and adjustment criterion: 1
    • additional file and logistic regression: 1
    • additional file and lymphocyte count: 1, 2, 3